SCHEMBL9997010

SCHEMBL9997010

Cc1ccc(Br)cc1S(=O)(=O)NC1(O)C=CC=CC1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 2/20 0.37
EDNRA P25101 2/20 0.37
KMT2A Q03164 1/20 0.37
MAPT P10636 3/20 0.36
TP53 P04637 2/20 0.36
IDH1 O75874 5/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
RPA1 P27694 2/20 0.33
GFER P55789 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CTSL P07711 1/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
CTSC P53634 1/20 0.32
MEP1B Q16820 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997385 0.80 POLB (0.41) KMT2ASMN1; SMN2GFERALDH1A1LMNA
SCHEMBL9997179 0.74 PTK2B (0.34) SMN1; SMN2LMNA
SCHEMBL9996879 0.71 KMT2A (0.41) KMT2AMAPTSMN1; SMN2GFERALDH1A1
SCHEMBL9997441 0.70 FBP1 (0.39)
SCHEMBL9997382 0.70 CA12 (0.44) KMT2AMAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL21857831 0.68 GAA (0.48) KMT2AMAPTALDH1A1
SCHEMBL9997302 0.67 KAT6A (0.42) MAPT
SCHEMBL9997528 0.66 KMT2A (0.48) KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL9997338 0.66 MEP1B (0.47) KMT2AALDH1A1MEP1BLMNA
SCHEMBL264514 0.65 LMNA (0.65) EDNRBEDNRAKMT2AMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011161201-A1 BISARYLSULFONAMIDES USEFUL AS KINASE INHIBITORS IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2011-12-29 WO disclosed